A New Research Hub for Imaging, Pharmacology, and Discovery in Cyprus
European University Cyprus (EUC) proudly announces the establishment of the Advanced Autoradiography and Radiopharmacology Centre (ARC). A new open-access research facility dedicated to high-resolution molecular imaging and quantitative pharmacology.
As the first centre of its kind in Cyprus, ARC provides real-time digital autoradiography and radioligand-based screening platforms to enable early phase drug discovery, advancing studies of drug-target interactions and the characterisation of novel molecular imaging agents. By opening its facilities to academic and industry partners, ARC fosters collaboration, drives innovation, and strengthens Cyprus’s position in translational biomedical research.
Located at the European University Cyprus campus in Nicosia, ARC is designed to serve both academic researchers and industry partners, offering access to cutting-edge technologies and expert scientific guidance. Through these collaborations, the Centre aims to enhance research capacity, foster innovation, and strengthen Cyprus’s position as a regional hub for biomedical excellence.
The Project is funded by the European Union Recovery and Resilience Facility of the NextGenerationEU instrument, through the Cypriot Research and Innovation Foundation Programme “Research Infrastructures” (Call: OPEN INFRASTRUCTURES/0625).
ARC’s day-to-day operations are overseen by a Steering Committee led by Project Coordinator Dr. Athanasios Metaxas, with three scientific liaisons:
- Dr. Irene Polycarpou, specialist in PET imaging
- Dr. Andreas Kalogirou, expert in chemistry
- Dr. Malamati Kourti, responsible for postgraduate training and education
With ARC, European University Cyprus reaffirms its commitment to advancing biomedical innovation, supporting interdisciplinary research, and connecting Cyprus to Europe’s growing network of scientific excellence.
